Remdesivir company CEO: It’s ‘not a cure, but a very significant treatment’
08:49
Share this -
copied
In the wake of a government-sponsored clinical trial that showed promising results for the experimental drug remdesivir to treat coronavirus, Daniel O’Day, chairman and CEO of Gilead Sciences, talks to TODAY in an NBC News exclusive. He says it’s “not a cure, but a very significant treatment” that can “reduce the time it takes patients to get better,” reducing the strain on health care systems. He promises Gilead will work to make the drug “accessible and affordable,” and says they are looking at ways to use the drug for other patients besides the most severely ill.May 1, 2020
UP NEXT
Sheinelle Jones speaks to an expert about the benefits of nature prescriptions | Wellness TODAY
06:52
Sheinelle Jones learns about three organizations making the outdoors more inclusive | Wellness TODAY
04:46
Sheinelle Jones learns tips to stay safe in nature | Wellness TODAY
04:11
Sheinelle Jones learns about a nonprofit making scuba diving more accessible | Wellness TODAY
03:36
Stroke survivor, 28, shares symptoms and warning signs
04:45
NYC's last public pay phones removed from Times Square